Imatinib Completed Phase N/A Trials for T-cell Childhood Acute Lymphoblastic Leukemia / L1 Childhood Acute Lymphoblastic Leukemia / Recurrent Childhood Acute Lymphoblastic Leukemia / Non-T, Non-B Childhood Acute Lymphoblastic Leukemia / L2 Childhood Acute Lymphoblastic Leukemia Treatment